Skip to main content

Table 1 Characteristics of patients with intracranial hemorrhage

From: Infective endocarditis and stroke: when does it bleed? A single center retrospective study

 

Age (years)

Sex

Hemorrhage

APT, IVT, AC, T < 24 h

Days after admission

Days after start Ab

Infection control

Premorbid mRS

Admission mRS

Discharge mRS

Hospital stay (weeks)

Surgery (days after admission)

1

74

M

HT (PH2)

APT

11

11

NA

1

3

3

10

Yes (190)

2

72

M

HT (PH1)

AC

0

Not startet

No

0

2

1

6

Yes (73)

3

58

M

Primary ICH

T

0

Not startet

No

0

2

6

2

No

4

42

F

HT (PH1)

T

0

Not startet

No

0

4

1

8

No

5

71

M

SAH

IVT/ T

1

Not startet

No

0

2

1

6

No

6

74

M

SAH

T/APT

1

1

No

0

1

6

1

Yes (7)

7

72

F

HT (PH1)

IVT

1

Not startet

No

?

5

6

2.5

No

8

90

M

Primary ICH

APT

12

9

Yes

4

4

6

4

No

9

66

M

HT (PH2)

AC/T

7

7

No

1

4

6

2

No

10

26

M

SAH, primary ICH, IIA

T

3

3

No

1

4

6

2

No

11

69

M

SAH, HT (PH2)

AC/T

0

Not startet

No

2

5

6

0.2

No

  1. Age, sex, type of hemorrhage, when it occurred, premorbid/admission/discharge mRS, hospital stay, cardiac surgery performed/ not performed and time of surgery are shown for each patient with intracranial hemorrhage. APT, IVT, AC or T in the last 24 h before intracranial hemorrhage, time of intracranial hemorrhage after start of antibiotic therapy and infection control (defined as negative blood culture > 48 h after start of antibiotic therapy and < 48 h before intracranial hemorrhage occurred) are depicted
  2. Ab antibiotic therapy, AC anticoagulation, APT antiplatelet therapy, ICH intracranial hemorrhage, IVT intravenous thrombolysis, HT hemorrhagic transformation of ischemic stroke, IIA intracranial infectious aneurysm, PH parenchymatous hematoma, SAH subarachnoidal hemorrhage, T thrombocytopenia